Alzamend Neuro, Inc. (ALZN)
Pharmaceutical Preparations
Latest Price
$1.31
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.57
P/B Ratio
2.28
Institutional Ownership
2.7% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 45.7K | -- | 1.07% | +18.2K | 2026-03-31 |
| VANGUARD FIDUCIARY TRUST CO | 21.0K | -- | 0.49% | -- | 2026-03-31 |
| MORGAN STANLEY | 18.0K | -- | 0.42% | -- | 2026-03-31 |
| Clearstead Advisors, LLC | 10.0K | -- | 0.23% | -- | 2026-03-31 |
| Tower Research Capital LLC (TRC) | 6.2K | -- | 0.15% | +4.1K | 2026-03-31 |
| CITIGROUP INC | 5.2K | -- | 0.12% | +5.2K | 2026-03-31 |
| UBS Group AG | 4.5K | -- | 0.11% | -20.1K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.4K | -- | 0.10% | -- | 2026-03-31 |
| BlackRock, Inc. | 437 | -- | 0.01% | -- | 2026-03-31 |
| SBI Securities Co., Ltd. | 22 | -- | 0.00% | -- | 2026-03-31 |